SYBE.US SYBLEU INC.

Healthcare Biotechnology USA Stocks
0.0550 USD
Close of Feb 26, 2025
0.0550 0.0550
Market cap
USD 584K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Dec 2023.

Is SYBE.US undervalued?

Graham number

The Graham number of SYBLEU INC. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SYBLEU INC. fundamental analysis

No fundamental analysis for SYBLEU INC. yet.

SYBLEU INC. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SYBLEU INC.

SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and is based in Bronx, New York. As of April 15, 2024, Sybleu Inc. operates as a sub…

Full company profile